Search - tctmd.com

Displaying 81 - 100 of 133

Sort: Relevancy | Date

Presentation TCT 2022

TCT 298: Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death

Presenter: David Hong

September 18, 2022

Presentation TCT 2022

TCT 297: Prevalence of Coronary Microvascular Disease in Patients with Non-Obstructive Coronary Artery Disease

Presenter: Carlos Collet

September 18, 2022

Presentation TCT 2022

TCT 296: Post-Spastic Flow Recovery Time to Document Vasospasm Induced Ischemia during Acetylcholine Provocation Testing.

Presenter: Janneke Woudstra

September 18, 2022

Presentation TCT 2022

TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial

Presenter: SHIGETAKA KAGEYAMA

September 18, 2022

Presentation TCT 2022

Addressing Microvascular Obstruction and No Reflow With a Novel Nanoscale Endovascular Image-Guided Interventional Tool (Pulse NanoMED)

Presenter: Omid Akhavan

September 17, 2022

Presentation TCT 2022

TCT 256: Diagnostic and Prognostic Characteristics of Microvascular Resistance Reserve: From the Multi-Center ILIAS Registry.

Presenter: Coen Boerhout

September 17, 2022

Presentation TCT 2022

Case #3: Symptomatic Microvascular Disease

Presenter: Nils Johnson

September 17, 2022

Presentation Cardiovascular Interventions 2021

The Microvascular Disease Conundrum: Who Should I Refer For Evaluation, What Tests Will They Perform, And What Treatments Might They Offer

Presenter: Jennifer A Tremmel

November 19, 2021

Presentation TCT 2021

Case-Based Presentation 5: INOCA – How to Diagnose and Treat Coronary Microvascular Dysfunction (CMD)

Presenter: Colin Berry

November 06, 2021

Presentation TCT 2021

How Do We Identify Patients With Microvascular Dysfunction and Define Their Risk (Pressure Wire, Angiography, MRI)?

Presenter: Adrian Banning

November 05, 2021

Presentation SCAD 2021

Can microvascular coronary dysfunction co-exist with SCAD?

Presenter: Tara Sedlak

January 30, 2021

Presentation TCT 2020

Optical Coherence Tomography to Assess Microvascular Lung Thrombosis in COVID-19

Presenter: Marco Ancona

October 14, 2020

Presentation TCT 2020

TCT 324: Non-Hyperemic Pressure Ratios and Their Relationship With Indices of Microvascular Function

Presenter: Cuneyt Ada

October 14, 2020

Presentation TCT 2020

TCT 325: Usefulness of Optical Coherence Tomography in Myocardial Infarction With Non-Obstructive Coronary Arteries

Presenter: Caterina Mas-Lladó

October 14, 2020

Presentation TCT 2020

TCT 323: How to Proceed Optimally With Chest Pain Patients and Nonobstructive Coronary Arteries as Well as MINOCA History: Long-Term Results From the AChPOL Registry

Presenter: Jacek Bil

October 14, 2020

Presentation TCT 2020

TCT 320: Unmasking Syndrome X by Angiographic and Artificial Intelligence Programs

Presenter: Tra Ngo

October 14, 2020

Presentation TCT 2020

TCT 322: Discordance Between Coronary Flow Reserve and the Index of Microcirculatory Resistance Post Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

Presenter: Klio Konstantinou

October 14, 2020

Presentation TCT 2020

TCT 319: Risk Stratification of All-Cause Mortality Using Resistive Reserve Ratio in Patients With No Obstructive Coronary Artery Disease

Presenter: Takumi Toya

October 14, 2020

Presentation TCT 2020

TCT 017: Ambient Temperature and Infarct Size, Microvascular Obstruction, Left Ventricular Function and Clinical Outcomes After STEMI

Presenter: Matheus Santos

October 14, 2020

Presentation TCT Abstracts Posters 2019

MOCA I Study – Microvascular Obstruction Treatment Efficacy Measured by Using Dynamic Microvascular Resistance (dMVR)

Presenter: Valgimigli M.

October 17, 2019

Advertisement

TCT 298: Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death

TCT 297: Prevalence of Coronary Microvascular Disease in Patients with Non-Obstructive Coronary Artery Disease

TCT 296: Post-Spastic Flow Recovery Time to Document Vasospasm Induced Ischemia during Acetylcholine Provocation Testing.

TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial

Addressing Microvascular Obstruction and No Reflow With a Novel Nanoscale Endovascular Image-Guided Interventional Tool (Pulse NanoMED)

TCT 256: Diagnostic and Prognostic Characteristics of Microvascular Resistance Reserve: From the Multi-Center ILIAS Registry.

Case #3: Symptomatic Microvascular Disease

The Microvascular Disease Conundrum: Who Should I Refer For Evaluation, What Tests Will They Perform, And What Treatments Might They Offer

Case-Based Presentation 5: INOCA – How to Diagnose and Treat Coronary Microvascular Dysfunction (CMD)

How Do We Identify Patients With Microvascular Dysfunction and Define Their Risk (Pressure Wire, Angiography, MRI)?

Can microvascular coronary dysfunction co-exist with SCAD?

Optical Coherence Tomography to Assess Microvascular Lung Thrombosis in COVID-19

TCT 324: Non-Hyperemic Pressure Ratios and Their Relationship With Indices of Microvascular Function

TCT 325: Usefulness of Optical Coherence Tomography in Myocardial Infarction With Non-Obstructive Coronary Arteries

TCT 323: How to Proceed Optimally With Chest Pain Patients and Nonobstructive Coronary Arteries as Well as MINOCA History: Long-Term Results From the AChPOL Registry

TCT 320: Unmasking Syndrome X by Angiographic and Artificial Intelligence Programs

TCT 322: Discordance Between Coronary Flow Reserve and the Index of Microcirculatory Resistance Post Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

TCT 319: Risk Stratification of All-Cause Mortality Using Resistive Reserve Ratio in Patients With No Obstructive Coronary Artery Disease

TCT 017: Ambient Temperature and Infarct Size, Microvascular Obstruction, Left Ventricular Function and Clinical Outcomes After STEMI

MOCA I Study – Microvascular Obstruction Treatment Efficacy Measured by Using Dynamic Microvascular Resistance (dMVR)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content